Genechron is a biotech company specialized in molecular diagnostics, in the analysis of molecular markers on tissues and biological samples.
Their services can be used for diagnostic purposes, for the transfer of human therapies from the pre-clinical field to the clinical field, for nutrigenetic analysis and for veterinary applications.
The company, founded in 2016, has subsequently received capital risk financing through the POR I.3 Venture Capital Fund of the Lazio Region through Lazio Innova Spa.